These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 32432713)

  • 21. Contemporary National Trends of Prostate Cancer Screening Among Privately Insured Men in the United States.
    Kim SP; Karnes RJ; Gross CP; Meropol NJ; Van Houten H; Abouassaly R; Shah ND
    Urology; 2016 Nov; 97():111-117. PubMed ID: 27527411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging.
    Eapen RS; Herlemann A; Washington SL; Cooperberg MR
    Curr Opin Urol; 2017 May; 27(3):205-209. PubMed ID: 28221220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in stage-specific incidence of prostate cancer in Norway, 1980-2010: a population-based study.
    Møller MH; Kristiansen IS; Beisland C; Rørvik J; Støvring H
    BJU Int; 2016 Oct; 118(4):547-55. PubMed ID: 26497872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation.
    Howard DH; Tangka FK; Guy GP; Ekwueme DU; Lipscomb J
    Health Aff (Millwood); 2013 Mar; 32(3):596-602. PubMed ID: 23459740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contemporary Trends in the Incidence of Metastatic Prostate Cancer Among US Men: Results from Nationwide Analyses.
    Dalela D; Sun M; Diaz M; Karabon P; Seisen T; Trinh QD; Menon M; Abdollah F
    Eur Urol Focus; 2019 Jan; 5(1):77-80. PubMed ID: 28753893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PSA screening and deaths from prostate cancer after diagnosis--a population based analysis.
    Wachtel MS; Nelius T; Haynes AL; Dahlbeck S; de Riese W
    Prostate; 2013 Sep; 73(12):1365-9. PubMed ID: 23649537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implications of the United States Preventive Services Task Force Recommendations on Prostate Cancer Stage Migration.
    Sheng IY; Wei W; Chen YW; Gilligan TD; Barata PC; Ornstein MC; Rini BI; Garcia JA
    Clin Genitourin Cancer; 2021 Feb; 19(1):e12-e16. PubMed ID: 32800474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation.
    Kensler KH; Pernar CH; Mahal BA; Nguyen PL; Trinh QD; Kibel AS; Rebbeck TR
    J Natl Cancer Inst; 2021 Jun; 113(6):719-726. PubMed ID: 33146392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stage-specific incidence rates and trends of prostate cancer by age, race, and ethnicity, United States, 2004-2014.
    Li J; Siegel DA; King JB
    Ann Epidemiol; 2018 May; 28(5):328-330. PubMed ID: 29678312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Trends in United States Prostate Cancer Incidence Rates by Age and Stage, 1995-2012.
    Hoffman RM; Meisner AL; Arap W; Barry M; Shah SK; Zeliadt SB; Wiggins CL
    Cancer Epidemiol Biomarkers Prev; 2016 Feb; 25(2):259-63. PubMed ID: 26646364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer in young men: An emerging young adult and older adolescent challenge.
    Bleyer A; Spreafico F; Barr R
    Cancer; 2020 Jan; 126(1):46-57. PubMed ID: 31553489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testing and referral patterns in the years surrounding the US Preventive Services Task Force recommendation against prostate-specific antigen screening.
    Hutchinson R; Akhtar A; Haridas J; Bhat D; Roehrborn C; Lotan Y
    Cancer; 2016 Dec; 122(24):3785-3793. PubMed ID: 27658175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Up-to-date Assessment of US Prostate Cancer Incidence Rates by Stage and Race: A Novel Approach Combining Multiple Imputation with Age and Delay Adjustment.
    Cook MB; Hurwitz LM; Geczik AM; Butler EN
    Eur Urol; 2021 Jan; 79(1):33-41. PubMed ID: 33092896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. US Preventive Services Task Force prostate-specific antigen screening guidelines result in higher Gleason score diagnoses.
    Gejerman G; Ciccone P; Goldstein M; Lanteri V; Schlecker B; Sanzone J; Esposito M; Rome S; Ciccone M; Margolis E; Simon R; Guo Y; Pentakota SR; Sadeghi-Nejad H
    Investig Clin Urol; 2017 Nov; 58(6):423-428. PubMed ID: 29124241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer screening practices and diagnoses in patients age 50 and older, Southeastern Michigan, pre/post 2012.
    Rezaee ME; Ward CE; Odom BD; Pollock M
    Prev Med; 2016 Jan; 82():73-6. PubMed ID: 26592690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.
    Joshi SS; Filson CP
    Cancer; 2020 Feb; 126(4):694-696. PubMed ID: 31794066
    [No Abstract]   [Full Text] [Related]  

  • 39. Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.
    Shoag J; Halpern JA; Lee DJ; Mittal S; Ballman KV; Barbieri CE; Hu JC
    J Urol; 2016 Oct; 196(4):1047-52. PubMed ID: 27060052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database.
    Bandini M; Mazzone E; Preisser F; Nazzani S; Zaffuto E; Marchioni M; Tian Z; Pompe RS; Tilki D; Graefen M; Shariat SF; Montorsi F; Saad F; Briganti A; Karakiewicz P
    Eur Urol Oncol; 2018 Sep; 1(4):314-320. PubMed ID: 31100253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.